The m6A epitranscriptome in cancer therapy resistance: From cellular plasticity and metabolic rewiring to immune escape and therapeutic targeting.
- DOI
- 10.1016/j.canlet.2026.218697
- Published
- 2026 Oct 1
- Container
- Cancer letters
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.canlet.2026.218697,
title = {The m6A epitranscriptome in cancer therapy resistance: From cellular plasticity and metabolic rewiring to immune escape and therapeutic targeting.},
author = {Yi Y and Lai J and Jian L and Tian Y and Zhang X and Zhang R},
year = {2026},
journal = {Cancer letters},
doi = {10.1016/j.canlet.2026.218697},
url = {https://doi.org/10.1016/j.canlet.2026.218697}
}RIS
TY - JOUR TI - The m6A epitranscriptome in cancer therapy resistance: From cellular plasticity and metabolic rewiring to immune escape and therapeutic targeting. AU - Yi Y AU - Lai J AU - Jian L AU - Tian Y AU - Zhang X AU - Zhang R PY - 2026 JO - Cancer letters DO - 10.1016/j.canlet.2026.218697 UR - https://doi.org/10.1016/j.canlet.2026.218697 ER -
APA
Y, Y., J, L., L, J., Y, T., X, Z., & R, Z. (2026). The m6A epitranscriptome in cancer therapy resistance: From cellular plasticity and metabolic rewiring to immune escape and therapeutic targeting.. Cancer letters. https://doi.org/10.1016/j.canlet.2026.218697
Source records
- pubmed · retrieved 2026-09-25T08:35:23.835Z